Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Journal of Islamic Medicine Journal of General Procedural Dermatology and Venereology Indonesia
Deltania, Rasinta Ayudya
Unknown Affiliation
Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Injeksi Vaksin Bacillus Calmette-Guérin (BCG) Sebagai Agen Imunoterapi Pada Kasus Kondiloma Akuminata Setyowatie, Lita; Deltania, Rasinta Ayudya
Journal of Islamic Medicine Vol 9, No 2 (2025): JOURNAL OF ISLAMIC MEDICINE EDISI SEPTEMBER 2025
Publisher : Faculty of Medicine and Health Science, Universitas Islam Negeri Maulana Malik Ibrahim

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18860/jim.v9i2.35175

Abstract

AbstrakLatar Belakang: Kondiloma akuminata adalah infeksi menular seksual yang disebabkan Human Papillomavirus (HPV). Bacille-Calmette-Guerin (BCG) adalah vaksin hidup yang dilemahkan dan termasuk salah satu agen imunoterapi yang dapat menjadi alternatif terapi kondiloma akuminata.. Laporan Kasus: Perempuan berusia 23 tahun dengan keluhan muncul kutil sewarna kulit sejak 1 bulan tanpa disertai gatal dan nyeri. Pemeriksaan venereologi tampak papul sewarna kulit, multipel, batas tegas, bentuk dan ukuran bervariasi Acetowhite (+).Pasien didiagnosis kondiloma akuminata dan diberikan terapi vaksin BCG injeksi intralesi 0,5 ml dosis tunggal. Kesimpulan : Vaksin BCG meningkatkan aktivitas berbagai sel imun yang dapat merangsang penyembuhan kutil kelamin. Terapi injeksi intralesi  tunggal 0,5 ml menunjukkan penurunan lesi pasca 1 bulan injeksi. Injeksi vaksin BCG intralesi dapat menjadi pilihan terapi untuk kondiloma akuminata dengan keuntungan seperti keamanan, harga lebih murah, dan mudah didapatkan
Successful management of generalized pustular psoriasis with cyclosporine in HIV-infected patient Deltania, Rasinta Ayudya; Yuniaswan, Anggun Putri
Journal of General - Procedural Dermatology and Venereology Indonesia Vol. 9, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Generalized pustular psoriasis (GPP) can be associated with human immunodeficiency virus (HIV) infection, making its management more challenging and complex. This case report aims to evaluate the effectiveness and safety of cyclosporine in HIV-associated GPP. Case illustration: A 31-year-old male with a six-year history of HIV on antiretroviral therapy presented with rapidly spreading erythematous plaques with scaling and patches, along with “lakes of pus”, involving 50% of the body surface area (BSA). He reported oral burning, dysgeusia, and odynophagia; tongue Gram stain showed budding yeast and pseudohyphae. The patient was diagnosed with GPP and oral candidiasis in the setting of HIV. Cyclosporine was started at 2.5 mg/kg/day and escalated to 5 mg/kg/day; supportive care included nystatin 4x400,000 IU (swish-and-retain), paracetamol 3x500 mg, 0.9% NaCl wet compresses to pustular areas, emollients for xerosis, and intravenous 0.9% NaCl for hydration. By day 9, BSA improved from 50% to 12% with no severe adverse effects, only fatigue and loss of appetite. Discussion: GPP, a rare severe psoriasis variant, may be exacerbated in HIV patients due to immune dysregulation and CD4+ T-cell decline. In this case, cyclosporine treatment and supportive care improved symptoms without severe adverse effects. Cyclosporine appeared effective with minimal infection risk compared to methotrexate. This case highlights the importance of tailored, cautious immune suppression to manage GPP in HIV and balancing efficacy with infection risk. Conclusion: Cyclosporine may be an effective option for managing GPP in HIV-infected patients with CD4+ decline when used cautiously with close monitoring for opportunistic infections.
Co-Authors Lita Setyowatie, Lita Yuniaswan, Anggun Putri